RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence
PAMELA I. ELLSWORTH
Abstract
PAMELA I. ELLSWORTH
Abstract
No AccessJournal of UrologyCLINICAL UROLOGY: Letters to the Editor1 Sep 2003RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence Pamela Ellsworth Pamela EllsworthPamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000080841.60873.b1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence." The Journal of Urology, 170(3), p. 928 References 1 : Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc1998; 46: 8. Google Scholar 2 : Oxybutynin and cognitive dysfunction. BMJ1997; 315: 1363. Google Scholar 3 : Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001; 41: 636. Crossref, Medline, Google Scholar 4 : A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry1987; 48: 20. Google Scholar 5 : Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology1977; 27: 783. Google Scholar 6 : Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol1994; 47: 337. Google Scholar Department of Urology, University of Massachusetts Medical School, University Campus, 55 Lake Ave., North, Worcester, Massachusetts 01655© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 170Issue 3September 2003Page: 928 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.MetricsAuthor Information Pamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author Expand All Advertisement PDF downloadLoading ...
OpenAlex reports 63 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
No AccessJournal of UrologyCLINICAL UROLOGY: Letters to the Editor1 Sep 2003RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence Pamela Ellsworth Pamela EllsworthPamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author View All Author Informationhttps://doi.org/10.1097/01.ju.0000080841.60873.b1AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: Therapeutic Efficacy of Extended Release Oxybutynin Chloride, and Immediate Release and Long Acting Tolterodine Tartrate in Children With Diurnal Urinary Incontinence." The Journal of Urology, 170(3), p. 928 References 1 : Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc1998; 46: 8. Google Scholar 2 : Oxybutynin and cognitive dysfunction. BMJ1997; 315: 1363. Google Scholar 3 : Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001; 41: 636. Crossref, Medline, Google Scholar 4 : A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatry1987; 48: 20. Google Scholar 5 : Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology1977; 27: 783. Google Scholar 6 : Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol1994; 47: 337. Google Scholar Department of Urology, University of Massachusetts Medical School, University Campus, 55 Lake Ave., North, Worcester, Massachusetts 01655© 2003 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 170Issue 3September 2003Page: 928 Advertisement Copyright & Permissions© 2003 by American Urological Association, Inc.MetricsAuthor Information Pamela Ellsworth Financial interest and/or other relationship with Bayer, Pfizer and Pharmacia. More articles by this author Expand All Advertisement PDF downloadLoading ...
Key concepts: Tolterodine, Oxybutynin, Medicine, Urology, Urinary incontinence, Pharmacology, Overactive bladder, Alternative medicine